MOSS BEACH, California
United States
36
2026-04-16
The entities that hold a legal rights for patent applications filed by inventor HASS PHILIP E.:
PHILIP E. HASS from MOSS BEACH, US has applied for patents for these inventions. The list has both pending applications and granted patents:
TIE2-BINDING AGENTS AND METHODS OF USE
#2 | 2024-10-03TIE2-BINDING AGENTS AND METHODS OF USE
#3 | 2023-03-02IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
#4 | 2022-07-07IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#5 | 2022-07-07IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#6 | 2022-06-30IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#7 | 2021-10-28Tie2-binding agents and methods of use
#8 | 2021-01-07Anti-interleukin-33 antibodies and uses thereof
#9 | 2020-12-10IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#10 | 2020-12-03IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#11 | 2020-12-03IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#12 | 2019-08-01IL-22 Fc fusion proteins
#13 | 2019-06-13Methods for treating metabolic syndrome using IL-22 Fc fusion proteins
#14 | 2019-06-13Methods of treating acute pancreatitis using IL-22 fc fusion proteins
#15 | 2019-06-13Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins
#16 | 2019-06-13IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
#17 | 2019-06-13IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
#18 | 2019-04-04IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#19 | 2019-03-28Anti-interleukin-33 antibodies and uses thereof
#20 | 2018-12-20Pharmaceutical compositions of IL-22 Fc fusion proteins
#21 | 2018-12-13IL-22 Fc FUSION PROTEIN AND METHODS OF USE
#22 | 2017-11-09Methods of accelerating or improving wound healing using IL-22 FC fusion proteins
#23 | 2017-10-12IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#24 | 2017-03-30Nucleic acids encoding IL-22 Fc fusion proteins
#25 | 2017-03-16IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#26 | 2017-01-12IL-22 Fc fusion proteins
#27 | 2016-06-16Anti-interleukin-33 antibodies and uses thereof
#28 | 2016-01-21Anti-factor D antibodies
#29 | 2015-08-20Antibodies directed to IL-17A/IL-17F heterodimers
#30 | 2014-10-23Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins
#31 | 2011-12-29IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#32 | 2008-07-03IL-17A/F heterologous polypeptides and therapeutic uses thereof
#33 | 2007-07-12IL-17A/F heterologous polypeptides and therapeutic uses thereof
#34 | 2006-11-30IL-17A/F heterologous polypeptides and therapeutic uses thereof
#35 | 2006-08-31Methods of treating coagulapathic or thrombotic disorders
#36 | 2006-04-27Human anti-factor IX/IXa antibodies
944073 ⎘